Who We Are

Get to Know KORU

KORU is, first and foremost, a patient-centric organization that will go the extra mile for our customers, providers, and partners who depend on our devices. We are a world-class manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).


Our Company Shared Values

Patient Experience: We are a patient-focused organization. Our number one priority is patient safety and patient efficacy.

Integrity: KORU Medical Systems is committed to conducting business with integrity. We hold every employee to the highest standard, to work in the best interest of our team, customers and most importantly, our patients. We are devoted to forging transparent, trusting relationships with our patients, employees, pharmaceutical partners, and investors.

Teamwork: We have reshaped the KORU team and Board and put the best people in place to deliver thought leadership in a collaborative, respectful fashion. We encourage our people to act entrepreneurially, to take measured risk, while providing them the institutional resources and training to succeed.


in each other


in everything we do


for actions and results

Market Driven

decision making


to learn and grow

Open Minded

to new ideas and change


for self and others


of our business and goal

Education: We stress authentic communication and training with our patient and clinical community. This demands responsiveness when answering questions, distributing comprehensive educational materials, and staying active in the PIDD and CIDP communities.

Who We Serve

Patients: We are a patient-centric organization through and through. We are focused on offering unparalleled subcutaneous infusion devices to deliver life-saving treatments to our patient community. In addition to enhancing patient experiences and providing them the freedom to infuse where and when they choose, we strive to involve ourselves within the patient community by providing resources, education, and support.

Patient Advocates: Patient advocates play a vital role in the PIDD and CIDP communities. Whether we are working with specialty pharmacists, nurses, doctors, or homecare providers, we strive to provide them the support and resources they need to serve as patient advocates.

Specialty Pharmacies: We work hard to establish long term relationships with specialty pharmacies and strive to be their trusted partners. We know specialty pharmacists seek safe and efficient medical devices for patients and we are committed to providing them with these products and the associated resources they require.

Distributors: Distributors play an integral role in getting patients the care they need. At KORU, we work closely with our distributors and ensure that we provide adequate educational materials, resources, and information to allow them to sell our products effectively.

Clinicians, Doctors & Nurses: Doctors and nurses play a vital role in the primary immunodeficiency and Chronic Inflammatory Demyelinating Polyneuropathy communities. We know how important it is for them to provide excellent patient care and therapeutic options to their patients. With this in mind, we are committed to offering an unparalleled infusion system and the associated educational resources for doctors and nurses to provide to their patients.

Investors: At KORU, we are dedicated to being a financially stable, accountable organization and have a commitment to transparent communication with each of our stakeholders. Investor relations is key to our success as an organization and at the forefront of each decision we make.

Home Infusion Made Simple

KORU has been amazing, as soon as I posted anything on social media with their pump, they reached out to me to see if there was anything I needed. It made me feel important and taken care of.

- KORU Patient

My experiences with KORU have been great. It seems like such a close-knit company since they are able to interact and engage with individual patients via social media channels, which isn’t always the case with big medical organizations. I know if I ever had an issue and needed to contact, KORU would help me to the best of their ability.

- KORU Patient

Our Story

Repro Med Systems, Inc., now operating as KORU Medical Systems, is a leading developer and manufacturer of medical devices and supplies. We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers with careful consideration to the patient experience. The company was incorporated in March 1980 and is now publicly traded on the NASDAQ Capital Market (NASDAQ: KRMD). We are located in Chester, NY (USA), just 60 miles northwest of New York City.

Our primary products include the Freedom Integrated Infusion System: the FREEDOM60® and FreedomEdge® Syringe Drivers, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets™

Worldwide, KORU Medical Systems drives healthcare inspiration – in the minds of our patients, our employees, our customers, and our shareholders – to give everyone greater freedom for living. Our products and customer service support are offered throughout the world through a global network of distributors and service providers. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We are excited to expand into new markets with innovative, technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

Our Executive Team

Chief Executive Officer and President

Linda Tharby

Chief Executive Officer and President

Ms. Tharby is an experienced global medical device industry executive, with a 24-year career with Becton Dickinson and Company (“BD”; NYSE: BDX), a leading medical technology company. Ms. Tharby was a member of the Executive Leadership team of BD that transformed the company from an $8 billion medical supplies company to an $18 billion global medical technology company. With over 20 years of experience in global business leadership roles, Ms. Tharby has been accountable for portfolio innovation and global commercialization across multiple business units. Ms. Tharby also has enterprise change and integration experience, with her most recent role at BD, from July 2018 through December 2020, as the company’s Chief Customer Experience Officer and in her prior role, as the company’s Chief Human Resources Officer, from October 2016 through July 2018, through BD’s $24 billion acquisition and integration of C.R. Bard in 2017. Prior to that, she served at BD as the Executive Vice President and President of the Life Sciences segment, Group President of Preanalytical Systems and BD Biosciences, Worldwide President of Diabetes Care, and Vice President and General Manager of Pharmaceutical Systems. Since 2014, Ms. Tharby has served on the Columbia University School of Public Health Board of Advisors.

Chief Financial Officer

Karen Fisher

Chief Financial Officer

Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles such as Chief Accounting Officer and Treasurer, and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management. She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s and Sarbanes-Oxley. Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.

Chief Operating Officer

Manuel Marques

Chief Operating Officer

Manny Marques has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques. Mr. Marques holds two U.S. patents for cardiovascular medical devices. Manny obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.

Vice President of Strategy and Business Development

Josh Bennett

Vice President of Strategy and Business Development

Mr. Bennett’s experience spans healthcare product categories, care settings, and end markets, including medical devices / technology, pharmaceuticals, biologics, acute care, and home care. He has been responsible for growth in both U.S. and international markets.

He joins KORU Medical from Salter Labs, a global anesthesia and respiratory medical device manufacturer, where he served as Vice President Sales, Marketing, and Business Development beginning in 2012. Salter Labs merged with SunMed in 2019. Prior to this, he was with Baxter Healthcare, a Fortune 500 diversified global pharmaceutical and device manufacturer. At Baxter he focused on pharmaceuticals and biologics, with an emphasis on product and market development addressing nutrition, hydration, and hemophilia. Mr. Bennett began his career at PwC Consulting (now IBM Global Business Services).

Mr. Bennett received his MBA from the Kellogg School of Management at Northwestern University, where he was a Siebel Scholar and recipient of the Richard M. Clewett Award, and his BBA from Northwood University.

Vice President of Business Development

Brian Hertzog

Vice President of Business Development

Brian Hertzog comes to Koru with over 15 years of experience in the drug delivery and medical device space. Most recently he was a business development executive at Nemera, a diversified drug delivery company with inhalation, ENT, ophthalmic, dermal, and parenteral devices (both autoinjectors and on-body wearables). He has deep experience in infusion devices and pharmaceutical packaging, also having held business development roles at Unilife, Schott, and Datwyler.

Vice President of Quality Assurance and Regulatory Affairs

Christopher Pazdan

Vice President of Quality Assurance and Regulatory Affairs

Chris joins the KORU team from Hillrom where he worked as the Vice President of Quality Assurance. In that role he was responsible for all quality functions for Hillrom’s largest manufacturing division. Prior to that role, Chris was the Vice President of QA/RA where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Chris’ proudest professional accomplishments include working with, leading, and helping build great teams. In addition to these efforts, he enjoys making a difference in the healthcare space and improving outcomes for patients and customers.

Chris received his bachelor’s degree in general engineering from the University of Illinois at Urbana-Champaign. He is a ASQ Certified Six Sigma Black Belt, ASQ Certified Quality Engineer and an ASQ Certified Quality Auditor.

Vice President of Medical Affairs

Brian Schiller, PhD

Vice President of Medical Affairs

Brian Schiller, PhD, is a senior leader with diverse medical affairs and clinical research experience spanning global strategic development, product launch, legal, regulatory and compliance alignment, recruitment and leadership of field medical teams, professional medical education, publication planning and medical communication strategy, company- and investigator-sponsored clinical research, medical marketing and health outcomes research. He has demonstrated success across a wide array of specialty areas including internal medicine, cardiology, endocrinology, immunology, neurology/neuropsychiatry, dermatology, orthopedics, general and gynecologic surgery.

Prior to joining RMS (now KORU Medical Systems), Dr. Schiller was Senior Director and Head of Field Medical, North America Medical Affairs at Sanofi (Genzyme) since 2009. From 2005-2008 Dr. Schiller worked at Avanir Pharmaceuticals; initially as an Associate Director of Medical Affairs, and later as Associate Director of Clinical Research and Medical Affairs. Dr. Schiller also held leadership roles at Amgen from 2002-2005 and at Bristol Myers Squibb from 1999-2002.

Vice President of Sales

Rob Cannon

Vice President of Sales

Rob brings 30+ years of experience in sales across the healthcare industry with direct experience in home care, specialty pharmacy and with Plasma/Biologics.  Most recently, he served as the Vice President of Strategic Accounts for McKesson Alternate Pharmacy Solutions, where he led the strategy, planning, and implementation of effective sales and marketing strategies focused on the specialty pharma channel. Prior to that role, Rob was the Vice President of Sales for McKesson Plasma and Biologics, where he established and managed a sales team, and as the Senior Director for McKesson Alternate Site Pharmacy, where he spearheaded the development and execution of strategic programs enhancing pharmacy partnerships while also driving value and efficiency. Rob received his Bachelor of Science degree in chemistry from Fordham University. 
Vice President of Financial Planning and Analysis

Tom Adams

Vice President of Financial Planning and Analysis

Tom joins KORU with medical device industry experience, coming from Integra Life Sciences, where he spent the last 10 years, with his most recent role there as Senior Director of Finance (FP&A).  Previous roles included Group Controller/Head of FP&A and Director of Finance (FP&A). Career highlights include establishing the Finance function for a newly created manufacturing division at Integra, which involved creating processes, setting up systems for reporting, management presentations and hiring a strong team. Tom recently led the financial analysis and negotiation to move Integra’s headquarters to Princeton, NJ, which this deal was recently awarded NJ’s 2019 office real estate deal of the year! He earned his Bachelor of Science in Business Administration-Accounting & Finance from Ohio State University. Tom brings extensive expertise and experience in building forecasts, budgets, modeling, and cost accounting that will support decision making and actions to help drive KORU’s growth.


We are always looking for dedicated, hard-working team members. If you have the skills and are seeking a challenging growth opportunity, please view our job postings below.

All Positions Offer Opportunity for Advancement

KORU offers a competitive salary and benefits package, including medical, dental, LTD and 401(k).

Current Openings